Outsourcing of NDA Approvals and CMO Performance in 2018 and Future Outlook | CPhI North America

 

View, browse and sort the ever-growing list of sessions by pass type, track, and format. With this Session Scheduler, you can build your schedule in advance and access it during the show via export or with the Mobile App, once live. Sessions do fill up and seating is first come, first serve, so arrive early to sessions that you would like to attend.

Outsourcing of NDA Approvals and CMO Performance in 2018 and Future Outlook

Peter Shapiro, PhD. (PhD., Editor-in-Chief and Director of the Drugs Business Fundamentals Databases, PharmSource and Pharma Intelligence Center)

Location: E353b

Date: Tuesday, April 30

Time: 11:45am - 12:30pm

Track: Drug Development

Vault Recording: TBD

We will present select key findings from the latest edition of CMO Scorecard: Outsourcing of NDA Approvals, our long running analysis of the CMO Industry, using NDA approvals as the primary indicator of performance. In addition we have recently integrated the PharmSource platform into the GlobalData Pharma Intelligence Center giving us access to pipeline, sales and clinical trials information. We will present key trends in the drug pipeline that will shape CMO service demand in the future.